|
A |
B |
C |
D |
E |
F |
G |
H |
I |
J |
K |
L |
M |
N |
O |
P |
Q |
R |
S |
T |
U |
V |
W |
X |
Y |
Z
Recent news on
Erythropoietin
Erythropoietin, the blood booster - 25 May 2007 Jurnalo,Erythropoietin, commonly known as EPO, is a glycoprotein hormone that is used in medicine to treat anemia while in sport it has become a popular doping
MIRCERA Receives Positive Opinion in Europe for the Treatment of ... - 25 May 2007 campus med,About MIRCERA MIRCERA, is a continuous erythropoietin receptor activator that shows a different activity at the receptor level characterized by a slower
Living in a bubble in the hope of glory - 25 May 2007 Independent Online,In theory, the tents have the same effect as injecting EPO, an artificial version of the hormone erythropoietin, which stimulates red blood cell production
Committee for Medicinal Products for Human Use Summary of Positive ... - 25 May 2007 PharmaLive.com (press release),...an antianaemic product (ATC Code B03XA03) that stimulates erythropoiesis by interaction with the erythropoietin receptor on progenitor cells in the bone
Biking, Doping and the Death of Racing - 25 May 2007 Spiegel Online,...forward to admit that they had used the endurance-enhancing hormone erythropoietin (EPO) during Telekom's successful run in the middle of the 1990s.
APS: MIRCERA Receives Positive Opinion in Europe for the ......... - 25 May 2007 ANP Pers Support,...activity in vivo, as well as an increased half-life, in contrast to erythropoietin. research-focused healthcare groups in the fields of pharmaceuticals and
Cycling: Landis' lawyer calls testing lab 'incompetent' - 25 May 2007 Independent,...in a row when the team was sponsored by Deutsche Telekom, yesterday admitted to using the banned substance erythropoietin (EPO) during the 1996 Tour.
Austria’s $1m fine may be way ahead - 25 May 2007 The Herald,...team which won the 1996 and '97 Tour de France with Bjarne Riis and Jan Ullrich, admitted yesterday to having used banned blood-boosting erythropoietin.
Human Placental Hypoxia-Inducible Factor-1 Expression Correlates ... - 25 May 2007 Am J Pathology (subscription)...transforming growth factor ß3 in the placenta, and vascular endothelial growth factor and erythropoietin in the maternal circulation.
Attenuation of Inflammation and Apoptosis by Pre- and ... - 25 May 2007 Am J Pathology (subscription)Erythropoietin and its analogues are known to affect the interaction between apoptosis and inflammation in brain, kidney, and myocardium.
Top German cyclist admits to doping - 25 May 2007 The Age,German Erik Zabel, one of the top cyclists of the past 15 years, has admitted taking the banned blood booster erythropoietin (EPO) while competing for
Amgen ratings on negative watch on product concerns - S&P - May 23, 2007 Forbes,...'Over the last several months, information has come to light that indicates that the use of Aranesp and other erythropoietin-stimulating agents in certain
Neose Announces Issuance of US Patent Providing Additional Patent ... - May 21, 2007 PharmaLive.com (press release),The patent, entitled "Erythropoietin: remodeling and glycoconjugation of erythropoietin," includes covalent conjugates of an erythropoietin peptide and a
FDA Panel warns anemia drug dangerous for cancer patients - May 14, 2007 News-Medical.net,A panel of experts advising the Food and Drug Administration (FDA) in the United States has warned that the popular anemia drug erythropoietin may not be as
Biopharma growing, but hurdles ahead - May 20, 2007 Times of India,Huge potential of these drugs can be gauged from the fact that the market for Erythropoietin (used to manage anaemia associated with cancer) is worth over
Best Drug, or Best Money Maker? (6 Letters) - May 12, 2007 New York Times,Our organization has long advocated evidence-based guidelines, including those we produced in 2002 with the American Society of Hematology on erythropoietin
Papp admits taking drugs, Landis set to testify - May 19, 2007 Malaysia Star,Joseph Papp, who holds dual Irish and American citizenship, said he graduated to testosterone after starting on EPO (erythropoietin) in 2001.
Debate on anemia drug delays a Roche launch - May 19, 2007 Therapeutics Daily (subscription) (press release),...on the use of the drugs - known as EPOs because they are made from the protein erythropoietin- to treat anemia in patients with chronic kidney disease.
In Cancer-Related Anemia Researchers Warn Caution In The Use Of ESAs - May 7, 2007 Medical News Today (press release),The ESAs darbepoetin alfa (Aranesp) and epoetin alfa (Epogen and Procrit) are genetically engineered forms of a protein called erythropoietin,
More twists in Landis case - May 19, 2007 The Age,A day before Landis was scheduled to testify, Joseph Papp said he graduated to testosterone after starting on erythropoietin (EPO) in 2001.
FDA Panel Highlights Safety Concerns of Anemia Drugs in Cancer ... - May 11, 2007 Newsinferno.com,Erythropoietin is in a class of drugs known as erythropoiesis-stimulating agents, or ESAs, which are intended to reduce the need for red blood cell
Stem Cell Enhancers? What a load of bollocks - May 16, 2007 ScienceBlogsFor example, remember the FDA review they just had about using erythropoietin to stimulate blood production during chemotherapy.
FDA panel warns of anemia drug risks - May 11, 2007 Science Daily (press release)WASHINGTON, May 11 (UPI) -- A US Food and Drug Administration panel is warning that the popular anemia drug erythropoietin may shorten the lives of some
FDA panel warns of anemia drug risks - May 11, 2007 Therapeutics Daily (subscription) (press release),A US Food and Drug Administration panel is warning that the popular anemia drug erythropoietin may shorten the lives of some cancer patients.
FDA panel warns of anemia drug risks - May 11, 2007 Monsters and Critics.com,WASHINGTON, DC, United States (UPI) -- A US Food and Drug Administration panel is warning that the popular anemia drug erythropoietin may shorten the lives
FDA panel warns of anemia drug risks - May 11, 2007 ImediNews,WASHINGTON, May 11 (UPI) — A US Food and Drug Administration panel is warning that the popular anemia drug erythropoietin may shorten the lives of some
FDA panel warns of anemia drug risks - May 11, 2007 NewKerala.com,WASHINGTON, May 11 : A US Food and Drug Administration panel is warning that the popular anemia drug erythropoietin may shorten the lives of some cancer
FDA panel warns of anemia drug risks - May 11, 2007 United Press International11 (UPI) -- A US Food and Drug Administration panel is warning that the popular anemia drug erythropoietin may shorten the lives of some cancer patients.
Safety concerns over EPO likely to hit pharma firms - May 16, 2007 Financial Express,MUMBAI, MAY 16: Indian pharmaceuticals firms, which have been marketing the much sought after biotech drug EPO (Erythropoietin), are likely to be hit by the
Anemia drug facing scrutiny; US gives out anti-terror grants. - May 10, 2007 Austin American-Statesman (subscription),...and Drug Administration gave strong signals that it thinks the blockbuster anemia drug called erythropoietin is overused in cancer treatment and might,
Market Report -- Short Stories (AMGN) - May 15, 2007 MSN Money...aftermarket, CMS issued, surprisingly severe policy restrictions for the use of erythropoietin stimulating agents in chemotherapy induced anemia and,
Long road ahead - May 24, 2007 Boston Globe,Cycling and doping have become so linked in recent years that Amgen , which invented the blood-boosting drug erythropoietin (EPO) frequently abused by
Derby Notebook - May 5, 2007 Washington Post,Use of erythropoietin is considered a Class A violation, Veitch said. If a Derby runner is found to have used the blood builder, the trainer could be
FDA warns of Exjade problems - May 23, 2007 Science Daily (press release)FDA panel warns of anemia drug risks (May 11, 2007) -- A US Food and Drug Administration panel is warning that the popular anemia drug erythropoietin may
Roche's New ESA* Effectively Stabilises Haemoglobin Levels In ... - 26 Apr 2007 Medical News Today (press release),Is a long-acting ESA designed to mimic the action of erythropoietin, a hormone produced by the kidneys to stimulate red blood cell production,
Kirin's NESP(R) Long-Acting Erythropoiesis Stimulating Agent ... - 26 Apr 2007 Japan Corporate News (press release),NESP(R) is manufactured by partially modifying the amino acid sequence of human erythropoietin (EPO) and attaching new sugar chains.
Beyond Biogenerics: The Real Threats for Therapeutic Proteins - 26 Apr 2007 PharmaLive.com (press release),...first approvals of biogeneric human growth hormone products in the US and the EU and first filings of biogeneric erythropoietin and insulin in the EU.
Medicines From Animal Cell Culture Report Addresses the Recent ... - Apr 25, 2007 PharmaLive.com (press release),...used to produce human and veterinary vaccines, interferon, monoclonal antibodies and genetically engineered products such as tPA and erythropoietin.
Erythropoietin drugs: What to know about anemia-fighting medications - Mar 29, 2007 MayoClinic.comIf you're undergoing hemodialysis for kidney disease or chemotherapy for cancer, you may be familiar with erythropoietin drugs that treat anemia — low red
‘For-profit Dialysis Centers’ in the Spotlight Over Anti-anemia ... - Apr 20, 2007 MedIndia,Healthy kidneys secrete a hormone called erythropoietin which is the catalyst behind the production of red blood cells in the bone marrow.
Darbepoetin Associated With Increased Mortality in Cancer Patients ... - Apr 19, 2007 DG News..."The evidence does not support the use of erythropoietin in these patients," Dr. Glaspy said in a late-breaker oral presentation on April 17 th .
Anemia drug trial's tardiness at issue - Apr 20, 2007 Los Angeles Times,Meanwhile, sales of the drugs, classified under the name erythropoietin and also sold by Johnson & Johnson under the brand name Procrit,
Convenient Dosing for Chemotherapy-Induced Anaemia: Presented at ASBD - Apr 18, 2007 DG NewsErythropoietin is usually administered on a weekly basis for the treatment of chemotherapy-induced anaemia. But newer dose-dense erythropoietin formulations
Data about Procrit - Apr 9, 2007 Citrus County Chronicle,Actually, Procrit is a man-made natural substance called erythropoietin. It is secreted by the kidney and it stimulates bone marrow to produce red blood
Plans for anemia drug run into roadblocks - Apr 8, 2007 Boston Globe,The problems mark another frustrating chapter in the development of the drug, a form of erythropoietin invented in the mid- 1990s by Dr. Arthur J. Sytkowski
Some Dialysis Centers Overtreat Anemia: Study - Apr 17, 2007 HealthCentral.com,Epoetin is a synthetic version of a hormone normally produced by the kidneys called erythropoietin. This hormone stimulates the bone marrow to produce red
Stem Cell Therapeutics Corp. Announces Positive Interim Results ... - Apr 10, 2007 PipelineReview.com (press release),Erythropoietin (EPO) is the second drug administered in the regimen, and aims to promote the differentiation of these newly formed NSCs into new neurons.
Public consent needed for emergency treatment - Apr 18, 2007 BCM News,The study is looking at the effects of an emergency treatment for head injury using erythropoietin, a medication that increases the production and lifespan
Some peddling doesn't fit for men on bikes - Apr 18, 2007 Sydney Morning Herald,...tells us that Amgen is the world's leading manufacturer of Aranesp and Epogen, synthetic versions of a drug called erythropoietin (EPO) which is used to
Stem Cell Announce Positive Interim Results From Phase IIa- Safety ... - Apr 10, 2007 Trading Markets,V | charts | news | PowerRating) on Tuesday reported positive interim results from its ongoing Phase IIa- Safety Trial study Beta-hCG + Erythropoietin in
New Human Cell-Produced Treatment for Anaemia Associated With ... - Mar 28, 2007 Drug Newswire (press release),DYNEPO is produced by activating the erythropoietin (EPO) gene in human cells . All other commercially available ESAs are presently made in animal cells.
MIRCERA(R) Effective in Stabilising Haemoglobin Levels in Elderly ... - Apr 23, 2007 PR Newswire Brasil (liberação de imprensa),About MIRCERA MIRCERA, a continuous erythropoietin receptor activator, is the first of a new class of long-acting chemically synthesized
Amgen details higher death risk in Aranesp trial - Apr 16, 2007 Reuters.uk,Some doctors have expressed concern that anemia drugs like Aranesp, which are forms of the red blood cell-boosting protein erythropoietin, may actually feed
DNAPrint(TM) Genomics` Advancements in PT-401 and Statinome ... - Apr 5, 2007 MacReport (press release),In one study, PT-401 was shown to be more potent and longer acting than epoetin alfa, a form of recombinant human erythropoietin currently in the market for
Ortho Biotech Revises Prescribing Information for PROCRIT(R ... - Apr 3, 2007 Drug Newswire (press release),If any patient develops a sudden loss of response to PROCRIT, accompanied by severe anemia and low reticulocyte count, and anti-erythropoietin
Aranesp(R) "145 Study" Shows No Difference In Survival In Patients ... - Apr 23, 2007 Medical News Today (press release),Cases of pure red cell aplasia (PRCA) and of severe anemia, with or without other cytopenias, associated with neutralizing antibodies to erythropoietin have
Lack of regulatory framework delays Indian cos’ US biogenerics entry - Apr 5, 2007 Financial Express,Wockhardt has developed six biotech products, including rhu insulin, r erythropoietin, Hepatitis E vaccine, and interferon alpha.
Amgen Delays on Earnings to Include Study Data - Apr 11, 2007 New York Times,Some doctors have expressed concern that anemia drugs like Aranesp, that are forms of the natural protein erythropoietin, may feed the growth of tumors.
REFILE-UPDATE 2-Amgen Delays Earnings to Include Trial Data - Apr 11, 2007 Reuters.uk,Some doctors have expressed concern that anemia drugs like Aranesp, that are forms of the natural protein erythropoietin, or EPO, may actually feed the
UPDATE 1-Amgen delays earnings report to include trial data - Apr 11, 2007 Reuters.uk,Some doctors have expressed concern that anemia drugs like Aranesp, whose active ingredient is erythropoietin, may actually be feeding the growth of tumors.
Silva banned for drug use - Apr 9, 2007 The Australian,PORTUGUESE runner Fernando Silva has been handed a two-year ban for using EPO (erythropoietin), according to the Portuguese athletics federation (FPA).
Portugal's runner Silva banned for EPO - Apr 8, 2007 Xinhua,LISBON, April 8 (Xinhua) -- Portuguese runner Fernando Silva was given a two-year ban for using EPO (erythropoietin), according to the Portuguese athletics
For-profit Dialysis Centres May Be Over-Treating Anemia - Apr 18, 2007 Medical News Today,Healthy kidneys produce a hormone called erythropoietin that stimulates bone marrow to make red blood cells. People with kidney disease don't make enough
Portugal's runner Silva banned for EPO - Apr 8, 2007 EastDay.com,Portuguese runner Fernando Silva was given a two-year ban for using EPO (erythropoietin), according to the Portuguese athletics federation (FPA) yesterday.
Portuguese runner Silva banned two years for positive test - Apr 7, 2007 People's Daily Online,The 27-year-old runner tested positive for erythropoietin on Dec. 4, the federation said Thursday. Silva has admitted to the offense.
Analysis: Street mixed on Amgen - Apr 24, 2007 United Press InternationalIt was a trying first quarter for the erythropoietin stimulating agents, or ESAs, which were hit with a black-box warning about the potential for increased
Medicare Payment Formula Results In Some For-Profit Dialysis ... - Apr 20, 2007 Medical News Today (press release),Dialysis centers administer Epogen, a synthetic form of the protein erythropoietin, to increase red blood cell, or hematocrit, levels in kidney disease
Anemia After Kidney Transplant Worsens Outcomes - Apr 18, 2007 MedPage Today,Caution patients that further study is needed to determine whether kidney transplant patients with anemia would benefit from erythropoietin therapy.
Study: Some Clinics Profit From Heavier Epogen Doses - Apr 18, 2007 International News Service,The FDA last month placed its most severe warning on the labels of erythropoietin products, which in addition to Epogen include Aranesp, another drug
Stem Cell Therapeutics Corp. Announces Positive Interim Results ... - Apr 10, 2007 CCNMatthews (press release),Of these, four patients have safely completed the NTx TM -265 regimen of human chorionic gonadotropin (hCG) and erythropoietin (EPO), initiated 24-48 hours
Stem Cell Therapeutics Corp. Announces Positive Interim Results ... - Apr 10, 2007 WM Experts (press release),Of these, four patients have safely completed the NTx™-265 regimen of human chorionic gonadotropin (hCG) and erythropoietin (EPO), initiated 24-48 hours
Darbepoetin Alfa Fails To Reduce The Need For Blood Transfusions ... - Apr 18, 2007 Medical News Today,Darbepoetin alfa is a synthetic form of erythropoietin, a hormone that signals the formation of new red blood cells from within the bone marrow.
Study: Some clinics profit from heavier Epogen doses - Apr 18, 2007 Boston Globe,The FDA last month placed its most severe warning on the labels of erythropoietin products, which in addition to Epogen include Aranesp , another drug
This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional
|